NCT03399214View on ClinicalTrials.gov

Phase Ib, Administration the IOP Injection for MRI Contrast Agent in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

May 1, 2018

Study Completion Date

July 31, 2018

Conditions
Magnetic Resonance Imaging
Interventions
DRUG

IOP Injection

T1 and T2

Trial Locations (1)

112

Taipei Veterans General Hospital, Taipei County

All Listed Sponsors
lead

MegaPro Biomedical Co. Ltd.

INDUSTRY

NCT03399214 - Phase Ib, Administration the IOP Injection for MRI Contrast Agent in Healthy Subjects | Biotech Hunter | Biotech Hunter